Embracing Bayesian Methods in Clinical Trials
This Perspective discusses the importance of the US Food and Drug Administration’s draft guidance on the use of bayesian methods in clinical trials because it underscores its commitment to modernizing clinical research.
Authors
- Lisa M. LaVange (ORCID: https://orcid.org/0000-0001-6755-6925)
- J. Jack Lee
- Frank E. Harrell
- David J. Spiegelhalter
Institutions
- University of North Carolina at Chapel Hill (US)
- The University of Texas MD Anderson Cancer Center (US)
- Vanderbilt University (US)
Publication Details
- Journal
- JAMA
- Published
- 2026-03-23
- DOI
- https://doi.org/10.1001/jama.2026.4179
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 0.00